Dr. Ece A. Mutlu, MD

Dr. Mutlu practices at University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System.

Dr. Mutlu's NPI, 1598707911, was assigned on June 11, 2006.

Dr. Mutlu's primary practice is University of Illinois Hospital, at 1740 West Taylor St Suite 1400, Chicago, IL 60612 in Cook County. The practice phone is (312) 996-3900.

Dr. Mutlu's primary practice is University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System. The medical group on file is Rush University Internists. Dmand AI also links Dr. Mutlu to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mutlu practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Mutlu's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Mutlu has a license on file in Illinois.

CMS data shows 140 Medicare services from Dr. Mutlu across 6 procedure codes in 2024, for 72 Medicare patients. Medicare paid $9,437 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 72 Medicare patients who saw Dr. Mutlu in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 58% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mutlu's median patient age at 63, with 64% women.

In 2024, Dr. Mutlu wrote 158 Medicare Part D claims for 50 patients. 59% of them were for generic drugs. CMS names the drug for 46 of them, across 3 drugs with 11 or more claims each, at $875 in total drug cost. In 2023, CMS named 94 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Mutlu for performance year 2024, reported as part of a group. Dr. Mutlu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mutlu as offering telehealth. CMS counts 20 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Mutlu, more than 50% of the clinicians it reports for that procedure.

Dmand AI links 50 papers to Dr. Mutlu, published from 2006 to 2025. 2015 was the busiest year, with 5. The most frequent topics are Inflammatory Bowel Diseases, Feces and Gastrointestinal Microbiome. Dr. Mutlu has published most often in PLoS One. Dr. Mutlu's most frequent co-authors are Ali Keshavarzian, MD, Cemal Yazici, MD and Rima Mansour Shobar, MD.

Dmand AI links Dr. Mutlu to 4 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Crohn Disease, Inflammatory Bowel Diseases and Short Bowel Syndrome.

CMS Open Payments shows 21 general payments to Dr. Mutlu from 3 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. Janssen Pharmaceuticals, Inc paid the most, $8,205.